Q23.4

Clinical Causes: Genetic factors: Certain genetic conditions or chromosomal abnormalities may play a role. Unknown reasons: The exact cause of HLHS in most cases is not clearly understood. Family history: A history of congenital heart defects in family members may increase risk. Environmental factors: Exposure to harmful substances during pregnancy could potentially contribute.

Key Symptoms: Cyanosis: A bluish tint to the skin, lips, or fingernails, especially during feeding or crying. Lethargy: Excessive tiredness or lack of energy. Difficulty breathing: Rapid breathing or shortness of breath. Poor feeding: Difficulty in feeding or tiring during feeds. Weak pulse: Especially in the lower extremities. Signs of heart failure: Swelling in the legs, abdomen, or around the eyes.

Diagnosis Path: Diagnosis often occurs shortly after birth through physical examination, where doctors may notice characteristic signs like cyanosis or a weak pulse. Confirmatory tests include echocardiography (ultrasound of the heart), which provides detailed images of the heart's structure, and sometimes cardiac MRI or catheterization. These assessments help determine the severity of hypoplasia and guide treatment planning.

Treatment Protocols: Managing hypoplastic left heart syndrome typically involves a series of complex surgical procedures aimed at rerouting blood flow within the heart. The primary approaches include: - **Stage I Surgery (Norwood Procedure):** Usually performed within the first week of life to create a new pathway for blood flow. - **Stage II Surgery (Glenn or Bidirectional Glenn Shunt):** Conducted at around 4-6 months of age, this reduces the workload on the heart. - **Stage III Surgery (Fontan Procedure):** Completed between 18 months to 3 years, this final step directs deoxygenated blood directly to the lungs. In addition to surgery, medical management includes medications to support heart function, oxygen therapy, and vigilant monitoring for complications. In some cases, a heart transplant may be considered if surgical options are limited or unsuccessful. Post-treatment, children require ongoing medical follow-up to monitor heart health, development, and address any emerging issues.